Prevalence of polycystic ovary syndrome in reproductive-aged women with type 2 diabetes

被引:15
作者
Amini, Massoud [1 ]
Horri, Negar [1 ]
Farmani, Mahboubeh [1 ]
Haghighi, Sassan [1 ]
Sattari, Ghoshtasb [1 ]
Pornaghshband, Zahra [1 ]
Aminorroaya, Ashraf [1 ]
机构
[1] Isfahan Univ Med Sci, Isfahan Endocrine & Metab Res Ctr, Esfahan, Iran
关键词
Type; 2; polycystic ovary syndrome; prevalence;
D O I
10.1080/09513590802306143
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background. Women with polycystic ovary syndrome ( PCOS) are at higher risk of type 2 diabetes and cardiovascular disease. The present study was conducted to investigate the prevalence of PCOS in type 2 diabetic patients. Methods. Type 2 diabetic women (n = 157) of reproductive age were selected by a convenience sampling method. PCOS was confirmed using the clinical diagnosis criteria proposed in 1990 by the National Institute of Child Health and Human Development Conference of PCOS. The diabetic patients were divided into two groups according to the presence of PCOS. Baseline demographic characteristics were obtained by questionnaire, and body weight, height, waist circumference, blood pressure and some biochemical indices were measured in both groups. Results. The prevalence of PCOS was high (8.3%, 95% confidence interval 4.5-13.4%) in these type 2 diabetic women. The onset of diabetes occurred at a lower age in the PCOS group, who also displayed significantly greater waist circumference and body mass index (p<50.05). No difference in lipid profile, glycosylated hemoglobin or blood pressure was observed between the two groups. Conclusions. PCOS is highly prevalent in type 2 diabetic patients. Hence, focusing the treatment on insulin sensitizers in these patients should improve both the metabolic and non-metabolic complications of PCOS.
引用
收藏
页码:423 / 427
页数:5
相关论文
共 18 条
[1]
Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization [J].
Birdsall, MA ;
Farquhar, CM ;
White, HD .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (01) :32-35
[2]
CARMINA ELR, 2000, ENDOCRINOL METAB, P941
[3]
The prevalence of polycystic ovaries in women with type 2 diabetes mellitus [J].
Conn, JJ ;
Jacobs, HS ;
Conway, GS .
CLINICAL ENDOCRINOLOGY, 2000, 52 (01) :81-86
[4]
A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile [J].
Diamanti-Kandarakis, E ;
Kouli, CR ;
Bergiele, AT ;
Filandra, FA ;
Tsianateli, TC ;
Spina, GG ;
Zapanti, ED ;
Bartzis, MI .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :4006-4011
[5]
PROFOUND PERIPHERAL INSULIN RESISTANCE, INDEPENDENT OF OBESITY, IN POLYCYSTIC OVARY SYNDROME [J].
DUNAIF, A ;
SEGAL, KR ;
FUTTERWEIT, W ;
DOBRJANSKY, A .
DIABETES, 1989, 38 (09) :1165-1174
[6]
Medical progress: Polycystic ovary syndrome [J].
Ehrmann, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (12) :1223-1236
[7]
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome [J].
Ehrmann, DA ;
Barnes, RB ;
Rosenfield, RL ;
Cavaghan, MK ;
Imperial, J .
DIABETES CARE, 1999, 22 (01) :141-146
[8]
Carotid atherosclerosis in women with polycystic ovary syndrome: Initial results from a case-control study [J].
Guzick, DS ;
Talbott, EO ;
SuttonTyrrell, K ;
Herzog, HC ;
Kuller, LH ;
Wolfson, SK .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (04) :1224-1229
[9]
Prevalence of polycystic ovary syndrome in girls aged 14-18 years in Isfahan, Iran [J].
Hashemipour, M ;
Faghihimani, S ;
Zolfaghary, B ;
Hovsepian, S ;
Ahmadi, F ;
Haghighi, S .
HORMONE RESEARCH, 2004, 62 (06) :278-282
[10]
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study [J].
Knochenhauer, ES ;
Key, TJ ;
Kahsar-Miller, M ;
Waggoner, W ;
Boots, LR ;
Azziz, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (09) :3078-3082